Get started
Author

Jun Fukihara

Observed names: Fukihara, Jun, J. Fukihara, 富貴原, 淳
ORCID: 0000-0001-7645-9158
Observed ORCID: 0000-0001-7645-9158
OpenAlex ID: A5059330853
Acute exacerbations of fibrotic interstitial lung diseases
2019 · Atsushi Suzuki, Yasuhiro Kondoh, et al. · Respirology · 178
PDF
Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors
2019 · Jun Fukihara, Koji Sakamoto, et al. · Clinical Lung Cancer · 114
GDNF‐mediated signaling via RET tyrosine 1062 is essential for maintenance of spermatogonial stem cells
2008 · Mayumi Jijiwa, Kumi Kawai, et al. · Genes to Cells · 91
PDF
Probable usual interstitial pneumonia pattern on chest CT: is it sufficient for a diagnosis of idiopathic pulmonary fibrosis?
2020 · Jun Fukihara, Yasuhiro Kondoh, et al. · European Respiratory Journal · 48
PDF
Nintedanib (OFEV) in the treatment of idiopathic pulmonary fibrosis
2016 · Jun Fukihara, Yasuhiro Kondoh · Expert Review of Respiratory Medicine · 27
Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study
2017 · Jun Fukihara, Hiroyuki Taniguchi, et al. · BMC Pulmonary Medicine · 24
PDF
COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases
2023 · Jun Fukihara, Yasuhiro Kondoh · Respiratory Investigation · 23
PDF
Clinical Predictors of Response to EGFR Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
2014 · Jun Fukihara, Naohiro Watanabe, et al. · Oncology · 23
Clinical burden of immune checkpoint inhibitor-induced pneumonitis
2020 · Koji Sakamoto, Jun Fukihara, et al. · Respiratory Investigation · 21
Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease
2024 · Tomonori Sato, Taiki Furukawa, et al. · Thorax · 19
PDF
Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting
2023 · Yoshikazu Mutoh, Takumi Umemura, et al. · Viruses · 19
PDF
BMP3b is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts
2022 · Atsushi Suzuki, Koji Sakamoto, et al. · American Journal of Respiratory Cell and Molecular Biology · 17
COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review
2022 · Yosuke Goto, Koji Sakamoto, et al. · Frontiers in Medicine · 17
PDF
Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
2023 · Reoto Takei, Toshiaki Matsuda, et al. · Frontiers in Medicine · 15
PDF
Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease
2015 · Jun Fukihara, Yasuhiro Kondoh, et al. · European Respiratory Journal · 12
Mitochondrial DNA in bronchoalveolar lavage fluid is associated with the prognosis of idiopathic pulmonary fibrosis: a single cohort study
2024 · Jun Fukihara, Koji Sakamoto, et al. · Respiratory Research · 10
Overexpression of bone morphogenetic protein receptor type 2 suppresses transforming growth factor β-induced profibrotic responses in lung fibroblasts
2022 · Jun Fukihara, Suzanne Maiolo, et al. · Experimental Lung Research · 8
Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease
2024 · Toshiaki Matsuda, Yasuhiro Kondoh, et al. · Respiratory Investigation · 5
Disease progression and changes in KL-6 in patients with limited cutaneous systemic sclerosis-associated interstitial lung disease
2023 · Reoto Takei, Yasuhiko Yamano, et al. · Respiratory Investigation · 5
Desaturation in the six-minute walk test predicts progressive pulmonary fibrosis in fibrotic interstitial lung disease
2025 · Reoto Takei, Jun Fukihara, et al. · Respiratory Investigation · 2
Reply to “Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors”
2019 · Jun Fukihara, Koji Sakamoto, et al. · Clinical Lung Cancer · 2
Early risk response to vasodilators and outcomes in interstitial lung disease associated pulmonary hypertension
2026 · Ryo Teramachi, Jun Fukihara, et al. · Respiratory Investigation · 1
Impact of Pulmonary Artery Pressure on the Response to Oxygen Administration for Exertional Desaturation in Interstitial Lung Disease
2025 · Jun Hirasawa, Ryo Teramachi, et al. · Respirology · 1
PDF
Clinical significance of histological inflammation in systemic sclerosis-associated interstitial lung disease
2025 · Shuko Hirota, Yasuhiko Yamano, et al. · Respiratory Investigation · 1
Idiopathic Pulmonary Fibrosis Incidentally Detected by Computed Tomography Scan as Interstitial Lung Abnormalities
2024 · Tomohiro Bando, Reoto Takei, et al. · Annals of the American Thoracic Society · 1
Works count: 55
Citation count: 687
H-index: 14
I10-index: 16
Year
Topic
Type